Alon Kushnir, RedDress CEO
May 24, 2023 07:00 AM EDT
Financing

Chron­ic wound biotech rais­es $26M in Se­ries D to ex­pand blood clot prod­ucts

Katherine Lewin

News Reporter

Wound care com­pa­ny Red­Dress, whose prod­ucts heal chron­ic wounds us­ing the pa­tient’s own blood, has raised $26 mil­lion in a Se­ries D fund­ing round. The …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

J&J part­ners on STAT6; As­traZeneca, Dai­ichi with­draw lung can­cer drug EMA app

BioN­Tech set­tles with NIH, UPenn in Covid vac­cine dis­putes and will pay roy­al­ties

FDA ap­proves sub­cu­ta­neous ver­sion of Bris­tol My­er­s' Op­di­vo

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

A service from the Financial Times